Clinical Benefit From BRAF/MEK Inhibition in a Double Non-V600E BRAF Mutant Lung Adenocarcinoma: A Case Report

著录项

• 来源
  《Clinical lung cancer》 |2019年第3期|共5页
• 作者

  Reyes Roxana; Mayo-de-las-Casas Clara; Teixido Cristina; Cabrera Carlos; Marin Elba; Vollmer Ivan; Jares Pedro; Garzon Monica; Angel Molina-Vila Miguel; Reguart Noemi;

  展开▼
• 作者单位

  Hosp Clin Barcelona Dept Med Oncol Villarroel 170 Barcelona 08036 Spain;

  Hosp Univ Quiron Dexeus Pangaea Oncol Barcelona Spain;

  Hosp Clin Barcelona Dept Pathol Barcelona Spain;

  Hosp Clin Barcelona Dept Med Oncol Villarroel 170 Barcelona 08036 Spain;

  Inst Invest Biomed August Pi I Sunyer IDIBA Translat Genom &

  Targeted Therapeut Solid Tumors;

  Hosp Clin Barcelona Dept Thorac Radiol Barcelona Spain;

  Hosp Clin Barcelona Dept Pathol Barcelona Spain;

  Hosp Univ Quiron Dexeus Pangaea Oncol Barcelona Spain;

  Hosp Univ Quiron Dexeus Pangaea Oncol Barcelona Spain;

  Hosp Clin Barcelona Dept Med Oncol Villarroel 170 Barcelona 08036 Spain;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词

  BRAF kinase activity; BRAF/MEK blockade; BRAF mutation; NGS; NSCLC;

  机译：漂亮的激酶活动;尼斯/梅克封锁;漂亮的突变;ngs;nsclc;